Complement inhibitor prevents disruption of sodium channel clusters in a rabbit model of Guillain–Barré syndrome
- 30 October 2008
- journal article
- Published by Elsevier
- Vol. 205 (1) , 101-104
- https://doi.org/10.1016/j.jneuroim.2008.09.016
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine modelBrain, 2008
- High affinity of anti‐GM1 antibodies is associated with disease onset in experimental neuropathyJournal of Neuroscience Research, 2006
- Complement inhibition abrogates nerve terminal injury in Miller Fisher syndromeAnnals of Neurology, 2005
- Acute motor axonal neuropathy: An antibody‐mediated attack on axolemmaAnnals of Neurology, 1996
- Immune attack on the schwann cell surface in acute inflammatory demyelinating polyneuropathyAnnals of Neurology, 1996
- High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments.Journal of Clinical Investigation, 1994
- FUT-175 as a potent inhibitor of C5/C3 convertase activity for production of C5a and C3aImmunology Letters, 1991
- Activation of terminal components of complement in patients with Guillain-Barré syndrome and other demyelinating neuropathies.Journal of Clinical Investigation, 1987
- Renal localization of the membrane attack complex in systemic lupus erythematosus nephritis.The Journal of Experimental Medicine, 1981
- New synthetic inhibitors of C1r̄, C1 esterase, thrombin, plasmin, kallikrein and trypsinBiochimica et Biophysica Acta (BBA) - Enzymology, 1981